Gemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia

被引：6

作者：

Awada, Hassan ^{[1
]}

Abdelmalek, Mina ^{[2
]}

Cronin, Tara ^{[1
]}

Baron, Jeffrey ^{[3
]}

Kashour, Zakariya ^{[2
]}

Azad, Farhan ^{[2
]}

Faisal, Muhammad Salman ^{[1
]}

Faber, Mark ^{[1
]}

Gravina, Matthew ^{[1
]}

Sung, Pamela J. ^{[1
,4
]}

Green, Steven D. ^{[1
]}

Przespolewski, Amanda ^{[1
]}

Thompson, James E. ^{[1
]}

Griffiths, Elizabeth A. ^{[1
]}

Wang, Eunice S. ^{[1
]}

机构：

[1] Roswell Pk Comprehens Canc Ctr, Dept Med, Leukemia Serv, Buffalo, NY 14203 USA

[2] SUNY Buffalo, Dept Med, Buffalo, NY USA

[3] Roswell Pk Comprehens Canc Ctr, Dept Pharm, Buffalo, NY USA

[4] Roswell Pk Comprehens Canc Ctr, Dept Pharmacol & Therapeut, Buffalo, NY USA

来源：

BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期

关键词：

ADULT PATIENTS; CHEMOTHERAPY; SURVIVAL;

D O I：

10.1038/s41408-023-00910-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 13 条

[1] Gemtuzumab ozogamicin for acute myeloid leukemia [J].

Appelbaum, Frederick R. ;

Bernstein, Irwin D. .

BLOOD, 2017, 130 (22) :2373-2376

[2] Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia [J].

Burnett, Alan K. ;

Russell, Nigel H. ;

Hills, Robert K. ;

Kell, Jonathan ;

Freeman, Sylvie ;

Kjeldsen, Lars ;

Hunter, Ann E. ;

Yin, John ;

Craddock, Charles F. ;

Dufva, Inge Hoegh ;

Wheatley, Keith ;

Milligan, Donald .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) :3924-3931

[3] Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial [J].

Burnett, Alan K. ;

Hills, Robert K. ;

Milligan, Donald ;

Kjeldsen, Lars ;

Kell, Jonathan ;

Russell, Nigel H. ;

Yin, John A. L. ;

Hunter, Ann ;

Goldstone, Anthony H. ;

Wheatley, Keith .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :369-377

[4] Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study [J].

Castaigne, Sylvie ;

Pautas, Cecile ;

Terre, Christine ;

Raffoux, Emmanuel ;

Bordessoule, Dominique ;

Bastie, Jean-Noel ;

Legrand, Ollivier ;

Thomas, Xavier ;

Turlure, Pascal ;

Reman, Oumedaly ;

de Revel, Thierry ;

Gastaud, Lauris ;

de Gunzburg, Noemie ;

Contentin, Nathalie ;

Henry, Estelle ;

Marolleau, Jean-Pierre ;

Aljijakli, Ahmad ;

Rousselot, Philippe ;

Fenaux, Pierre ;

Preudhomme, Claude ;

Chevret, Sylvie ;

Dombret, Herve .

LANCET, 2012, 379 (9825) :1508-1516

[5] Criteria for defining a complete remission in acute myeloid leukaemia revisited.: An analysis of patients treated in HOVON-SAKK co-operative group studies [J].

de Greef, GE ;

van Putten, WJL ;

Boogaerts, M ;

Huijgens, PC ;

Verdonck, LF ;

Vellenga, E ;

Theobald, M ;

Jacky, E ;

Löwenberg, B .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) :184-191

[6] Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study [J].

Delaunay, Jacques ;

Recher, Christian ;

Pigneux, Arnaud ;

Witz, Francis ;

Vey, Norbert ;

Blanchet, Odile ;

Lefebvre, Pascale ;

Luquet, Isabelle ;

Guillerme, Isabelle ;

Volteau, Christelle ;

Gyan, Emmanuel ;

Lioure, Bruno ;

Jourdan, Eric ;

Bouscary, Didier ;

Guieze, Romain ;

Randriamalala, Edouard ;

Uribe, Mario E. Ojeda ;

Dreyfus, Francois ;

Lacombe, Catherine ;

Bene, Marie-christine ;

Cahn, Jean-Yves ;

Harousseau, Jean-Luc ;

Ifrah, Norbert .

BLOOD, 2011, 118 (21) :37-38

[7] Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial [J].

Doehner, Hartmut ;

Weber, Daniela ;

Krzykalla, Julia ;

Fiedler, Walter ;

Kuehn, Michael W. M. ;

Schroeder, Thomas ;

Mayer, Karin ;

Luebbert, Michael ;

Wattad, Mohammed ;

Goetze, Katharina ;

Fransecky, Lars ;

Koller, Elisabeth ;

Wulf, Gerald ;

Schleicher, Jan ;

Ringhoffer, Mark ;

Greil, Richard ;

Hertenstein, Bernd ;

Krauter, Juergen ;

Martens, Uwe M. ;

Nachbaur, David ;

Abu Samra, Maisun ;

Machherndl-Spandl, Sigrid ;

Basara, Nadezda ;

Leis, Claudia ;

Schrade, Anika ;

Kapp-Schwoerer, Silke ;

Cocciardi, Sibylle ;

Bullinger, Lars ;

Thol, Felicitas ;

Heuser, Michael ;

Paschka, Peter ;

Gaidzik, Verena I. ;

Saadati, Maral ;

Benner, Axel ;

Schlenk, Richard F. ;

Doehner, Konstanze ;

Ganser, Arnold .

LANCET HAEMATOLOGY, 2023, 10 (07) :e495-e509

[8] Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN [J].

Doehner, Hartmut ;

Wei, Andrew H. ;

Appelbaum, Frederick R. ;

Craddock, Charles ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Godley, Lucy A. ;

Hasserjian, Robert P. ;

Larson, Richard A. ;

Levine, Ross L. ;

Miyazaki, Yasushi ;

Niederwieser, Dietger ;

Ossenkoppele, Gert ;

Roellig, Christoph ;

Sierra, Jorge ;

Stein, Eytan M. ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wang, Jianxiang ;

Wierzbowska, Agnieszka ;

Lowenberg, Bob .

BLOOD, 2022, 140 (12) :1345-1377

[9] Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials [J].

Hills, Robert K. ;

Castaigne, Sylvie ;

Appelbaum, Frederick R. ;

Delaunay, Jacques ;

Petersdorf, Stephen ;

Othus, Megan ;

Estey, Elihu H. ;

Dombret, Herve ;

Chevret, Sylvie ;

Ifrah, Norbert ;

Cahn, Jean-Yves ;

Recher, Christian ;

Chilton, Lucy ;

Moorman, Anthony V. ;

Burnett, Alan K. .

LANCET ONCOLOGY, 2014, 15 (09) :986-996

[10] FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia [J].

Norsworthy, Kelly J. ;

Ko, Chia-Wen ;

Lee, Jee Eun ;

Liu, Jiang ;

John, Christy S. ;

Przepiorka, Donna ;

Farrell, Ann T. ;

Pazdur, Richard .

ONCOLOGIST, 2018, 23 (09) :1103-1108

← 1 2 →